模塑科技(000700.SZ):2023年上半年醫院心臟病中心業務量增長明顯
格隆匯7月27日丨有投資者向模塑科技(000700.SZ)提問:醫院目前的經營情況?
模塑科技回覆:明慈醫院攜手國際享有盛譽的德國北威州心臟與糖尿病中心(HDZ)及國內優秀醫院,以心血管病、糖尿病和消化病為專科方向。
2022年公司通過引進華醫心誠醫生集團優質的醫療專家和技術資源,帶動醫院心血管學科建設、人才培養、技術提升和擴大品牌影響力,進行深度合作,共同構建長三角泛血管疾病聯盟,搭建一體化遠程會診平台。在知名度逐步擴大的同時,內部管理效率穩步提升,2023年上半年醫院心臟病中心業務量增長明顯。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.